Differential impact of ApoE ε4 on cortical activation during famous face recognition in cognitively intact individuals and patients with amnestic mild cognitive impairment

Alzheimer Disease and Associated Disorders

Volumn 25, Issue 3, 2011, Pages 250-261

  Frank, Gabriele ^a   Hennig Fast, Kristina ^c   Klünemann, Hans H ^a   Schmitz, Gerd ^b   Greenlee, Mark W ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Alzheimer disease; amnestic mild cognitive impairment; ApoE genotype; famous faces recognition; fMRI; medial temporal lobe

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; ALLELE; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BRAIN CORTEX; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; EVENT RELATED POTENTIAL; FACE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC RISK; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HUMAN; LEFT HEMISPHERE; MALE; MILD COGNITIVE IMPAIRMENT; PARAHIPPOCAMPAL GYRUS; PRIORITY JOURNAL; RECOGNITION; TASK PERFORMANCE; VOXEL BASED MORPHOMETRY;

AMNESIA; APOLIPOPROTEIN E4; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PATTERN RECOGNITION, VISUAL; RECOGNITION (PSYCHOLOGY);

EID: 80052260424     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e3182061636     Document Type: Article

References (61)

1. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183-194. (Pubitemid 39222988)
2. Blacker D, Tanzi RE. The genetics of Alzheimer disease: Current status and future prospects. Arch Neurol. 1998;55:294-296. (Pubitemid 28146192)
3. Weiner MF, Vega G, Risser RC, et al. Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease. Biol Psychiatry. 1999;45:633-638. (Pubitemid 29147373)
4. St George-Hyslop PH. Molecular genetics of Alzheimer's disease. Biol Psychiatry. 2000;47:183-199. (Pubitemid 30077395)
5. Schmidtke K, Hermeneit S. High rate of conversion to Alzheimer's disease in a cohort of amnestic MCI patients. Int Psychogeriatr. 2008;20:96-108. (Pubitemid 350256058)
6. Dickerson BC, Salat DH, Greve DN, et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology. 2005;65:404-411. (Pubitemid 41099803)
7. Rosano C, Aizenstein HJ, Cochran JL, et al. Event-related functional magnetic resonance imaging investigation of executive control in very old individuals with mild cognitive impairment. Biol Psychiatry. 2005;57:761-767. (Pubitemid 40487920)
8. Hamalainen A, Pihlajamaki M, Tanila H, et al. Increased fMRI responses during encoding in mild cognitive impairment. Neurobiol Aging. 2007;28:1889-1903. (Pubitemid 47539695)
9. Miller SL, Fenstermacher E, Bates J, et al. Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline. J Neurol Neurosurg Psychiatry. 2008;79:630-635. (Pubitemid 351829432)
10. Petrella JR, Wang L, Krishnan S, et al. Cortical deactivation in mild cognitive impairment: High-field-strength functional MR imaging. Radiology. 2007;245:224-235. (Pubitemid 47417806)
11. Xu G, McLaren DG, Ries ML, et al. The influence of parental history of Alzheimer's disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory. Brain. 2009;132(Pt 2):383-391.
12. Seidenberg M, Guidotti L, Nielson KA, et al. Semantic memory activation in individuals at risk for developing Alzheimer disease. Neurology. 2009;73:612-620.
13. Bondi MW, Houston WS, Eyler LT, et al. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology. 2005;64:501-508. (Pubitemid 40189870)
14. Wishart HA, Saykin AJ, Rabin LA, et al. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele. Am J Psychiatry. 2006;163: 1603-1610. (Pubitemid 44465762)
15. Lind J, Persson J, Ingvar M, et al. Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers. Brain. 2006;129(Pt 5):1240-1248.
16. Trivedi MA, Schmitz TW, Ries ML, et al. Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: A crosssectional study. BMC Med. 2006;4:1-14.
17. Borghesani PR, Johnson LC, Shelton AL, et al. Altered medial temporal lobe responses during visuospatial encoding in healthy APO.E. 4 carriers. Neurobiol Aging. 2008;29:981-991. (Pubitemid 351697985)
18. Filbey FM, Slack KJ, Sunderland TP, et al. Functional magnetic resonance imaging and magnetoencephalography differences associated with APOEepsilon4 in young healthy adults. Neuroreport. 2006;17:1585-1590. (Pubitemid 44454761)
19. Ahmed S, Arnold R, Thompson SA, et al. Naming of objects, faces and buildings in mild cognitive impairment. Cortex. 2008; 44:746-752. (Pubitemid 351727860)
20. Joubert S, Felician O, Barbeau EJ, et al. Patterns of semantic memory impairment in mild cognitive impairment. Behav Neurol. 2008;19:35-40. (Pubitemid 351521557)
21. Thompson SA, Graham KS, Patterson K, et al. Is knowledge of famous people disproportionately impaired in patients with early and questionable Alzheimer's disease? Neuropsychology. 2002;16:344-358. (Pubitemid 34778900)
22. Vogel A, Gade A, Stokholm J, et al. Semantic memory impairment in the earliest phases of Alzheimer's disease. Dement Geriatr Cogn Disord. 2005;19:75-81. (Pubitemid 40868031)
23. Elfgren C, van Westen D, Passant U, et al. fMRI activity in the medial temporal lobe during famous face processing. Neuroimage. 2006;30:609-616.
24. Kanwisher N, Yovel G. The fusiform face area: A cortical region specialized for the perception of faces. Philos Trans R Soc. 2006;361:2109-2128. (Pubitemid 46025883)
25. Braak H, Braak E. Neuropathological staging of Alzheimerrelated changes. Acta Neuropathol. 1991;82:239-259.
26. Dickerson BC, Sperling RA. Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: Insights from functional MRI studies. Neuropsychologia. 2008;46:1624-1635.
27. Kalpouzos G, Chetelat G, Baron JC, et al. Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol Aging. 2009;30: 112-124.
28. Chetelat G, Desgranges B, de la Sayette V, et al. Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology. 2003;60:1374-1377. (Pubitemid 36461002)
29. Quade O. Rank analysis of covariance. J Am Stat Assoc. 1967;62:1187-1200.
30. Artero S, Petersen R, Touchon J, et al. Revised criteria for mild cognitive impairment: Validation within a longitudinal population study. Dement Geriatr Cogn Disord. 2006;22:465-470. (Pubitemid 44726018)
31. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I: Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989;39:1159-1165. (Pubitemid 19239715)
32. Folstein MF, Folstein SE, McHugh PR. "Mini Mental State" : A practical method for grading the cognitive status of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
33. Kramer JH, Nelson A, Johnson JK, et al. Multiple cognitive deficits in amnestic mild cognitive impairment. Dement Geriatr Cogn Disord. 2006;22:306-311. (Pubitemid 44651444)
34. Hennig-Fast K, Fujiwara E, Markowitsch HJ. Famous Faces Test. Göttingen, Germany: Hogrefe Verlag; 2008.
35. Näsänen R. Spatial frequency bandwidth used in the recognition of facial images. Vis Res. 1999;39:3824-3833.
36. Maldjian JA, Laurienti PJ, Kraft RA, et al. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage. 2003;19: 1233-1239. (Pubitemid 36918259)
37. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI singlesubject brain. Neuroimage. 2002;15:273-289. (Pubitemid 34852226)
38. Meisenzahl EM, Koutsouleris N, Gaser C, et al. Structural brain alterations in subjects at high-risk of psychosis: A voxelbased morphometric study. Schizophr Res. 2008;102:150-162.
39. Meisenzahl EM, Koutsouleris N, Bottlender R, et al. Structural brain alterations at different stages of schizophrenia: A voxelbased morphometric study. Schizophr Res. 2008;104:44-60.
40. Good CD, Johnsrude IS, Ashburner J, et al. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage. 2001;14(1 Pt 1):21-36. (Pubitemid 32552740)
41. Desmond JE, Glover GH. Estimating sample size in functional MRI (fMRI) neuroimaging studies: Statistical power analyses. J Neurosci Meth. 2002;118:115-128. (Pubitemid 36151632)
42. Thirion B, Pinel P, Meriaux S, et al. Analysis of a large fMRI cohort: Statistical and methodological issues for group analyses. Neuroimage. 2007;35:105-120.
43. Nielson KA, Seidenberg M, Woodard JL, et al. Common neural systems associated with the recognition of famous faces and names: An event-related fMRI study. Brain Cogn. 2010; 72:491-498.
44. Haxby JV, Hoffman EA, Gobbini MI. Human neural systems for face recognition and social communication. Biol Psychiatry. 2002;51:59-67. (Pubitemid 34093794)
45. Pourtois G, Schwartz S, Seghier ML, et al. View-independent coding of face identity in frontal and temporal cortices is modulated by familiarity: An event-related fMRI study. Neuroimage. 2005;24:1214-1224. (Pubitemid 40164523)
46. Kanwisher N, Yovel G. The fusiform face area: A cortical region specialized for the perception of faces. Philos Trans R Soc Lond B Biol Sci. 2006;361:2109-2128. (Pubitemid 46025883)
47. Johnson SC, Schmitz TW, Moritz CH, et al. Activation of brain regions vulnerable to Alzheimer's disease: The effect of mild cognitive impairment. Neurobiol Aging. 2006;27: 1604-1612. (Pubitemid 44363104)
48. Ries ML, Schmitz TW, Kawahara TN, et al. Task-dependent posterior cingulate activation in mild cognitive impairment. Neuroimage. 2006;29:485-492. (Pubitemid 43063305)
49. Bellgowan PSF, Bandettini PA, van Gelderen P, et al. Improved BOLD detection in the medial temporal lobe region using parallel imaging and voxel volume reduction. Neuro- Image. 2006;29:1244-1251. (Pubitemid 43184187)
50. Thompson PM, Hayashi KM, de Zubicaray G, et al. Dynamics of gray matter loss in Alzheimer's disease. J Neurosci Meth. 2003;23:994-1005. (Pubitemid 36206191)
51. Celone KA, Calhoun VD, Dickerson BC, et al. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: An independent component analysis. J Neurosci. 2006;26:10222-10231. (Pubitemid 44527415)
52. Blacker D, Haines JL, Rodes L, et al. ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics initiative. Neurology. 1997;48:139-147. (Pubitemid 27039532)
53. Ritchie K. Mild cognitive impairment: An epidemiological perspective. In: Macher J-P, ed. Dialogues in Clinical Neuroscience. Mild Cognitive Impairment. Neuilly-sur-Seine Cedex, France: Les Laboratoires Servier; 2004:401-408. (Pubitemid 40052071)
54. Westen D, Blagov PS, Harenski K, et al. Neural bases of motivated reasoning: An FMRI study of emotional constraints on partisan political judgment in the 2004 US Presidential election. J Cogn Neurosci. 2006;18:1947-1958. (Pubitemid 44674292)
55. Mohanty A, Gitelman DR, Small DM, et al. The spatial attention network interacts with limbic and monoaminergic systems to modulate motivation-induced attention shifts. Cereb Cortex. 2008;18:2604-2613.
56. Stern Y, Habeck C, Moeller J, et al. Brain networks associated with cognitive reserve in healthy young and old adults. Cereb Cortex. 2005;15:394-402. (Pubitemid 40388240)
57. Cherbuin N, Leach LS, Christensen H, et al. Neuroimaging and APOE genotype: A systematic qualitative review. Dement Geriatr Cogn Disord. 2007;24:348-362. (Pubitemid 350036691)
58. Ashburner J, Friston KJ. Voxel-based morphometry-the methods. Neuroimage. 2000;11:805-821.
59. Rodionov R, Chupin M, Williams E, et al. Evaluation of atlasbased segmentation of hippocampi in healthy humans. Magn Reson Imaging. 2009;27:1104-1109.
60. Tang Y-P, Gershon ES. Genetic studies in Alzheimer's disease. In: Macher J-P, ed. Dialogues in Clinical Neuroscience. Dementia. Neuilly-sur-Seine Cedex-France: Les Laboratoires Servier; 2003:17-26. (Pubitemid 36806540)
61. Hayden KM, Zandi PP, West NA, et al. Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: The Cache County Study. Arch Neurol. 2009;66:1378-1383.